Akebia Therapeutics, Inc. (NASDAQ:AKBA) has 165 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 521,394 | 2.77% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 468,940 | 3.02% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | -215,417 | -6.72% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -529,811 | -36.46% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 1,842,792 | 15.56% | $0.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 0 | 444,498 | 57.09% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,871 | 100.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 92,226 | 1.49% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -2,774,699 | -76.10% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 2,938,624 | 166.23% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | -1,708,386 | -74.23% | $0.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 0 | 1,479,711 | 46.45% | $0.00 |
| Hennion & Walsh Asset Management, Inc. | 31 Dec, 2025 | 0 | 498,961 | 0.00% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | -359,594 | -9.10% | $0.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 0 | 472,485 | 0.00% | $0.00 |
| Citigroup Inc | 31 Dec, 2025 | 0 | 519,511 | 27.10% | $0.00 |
| Aquatic Capital Management LLC | 31 Dec, 2025 | 0 | -212,624 | -41.95% | $0.00 |
| Northern Trust Corp | 31 Dec, 2025 | 0 | -173,302 | -6.97% | $0.00 |
| Man Group plc | 31 Dec, 2025 | 0 | 84,169 | 67.65% | $0.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 0 | -1,319,589 | -36.89% | $0.00 |